Literature DB >> 22406338

Suicidal ideation and the subjective aspects of depression.

John G Keilp1, Michael F Grunebaum, Marianne Gorlyn, Simone LeBlanc, Ainsley K Burke, Hanga Galfalvy, Maria A Oquendo, J John Mann.   

Abstract

BACKGROUND: Suicidal ideation is common in depression, but only moderately related to depression severity - in part because certain clusters of symptoms, such as those related to core mood disturbance, have a differential relationship to suicidal thinking.
METHODS: 400 medication free participants with current major depression were assessed with either or both the Hamilton Depression Rating Scale (HDRS, n=396) and Beck Depression Inventory (BDI, n=366), and the Scale for Suicide Ideation (SSI). Depression rating scales were decomposed into symptoms clusters previously reported (Grunebaum et al., 2005), in order to evaluate their association to suicidal thinking.
RESULTS: Correlations between overall depression severity ratings and the measure of suicidal ideation were modest, and reduced when specific items assessing suicidal thinking on these depression scales were removed. Symptom clusters assessing Psychic Depression (HDRS), Subjective Depression (BDI), and Self-Blame (BDI) were the strongest correlates of suicidal ideation; other somatic and vegetative symptoms had little or no association to suicidal ideation. Severity of these symptom clusters effectively discriminated those with (SSI>0) and without (SSI=0) ideation; severity of these symptom clusters was less strongly associated with the severity of ideation once ideation was present. LIMITATIONS: This is a cross-sectional study, and the dynamic relationship between changes in the severity of various depressive symptoms and change in suicidal thinking remains to be explored.
CONCLUSIONS: Depression severity is moderately associated with suicidal ideation, and accounted for primarily by core mood disturbance symptoms and self-punitive thinking. These associations may explain why suicide risk might remain high during treatment even though somatic and vegetative symptoms improve.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22406338      PMCID: PMC3375058          DOI: 10.1016/j.jad.2012.01.045

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  30 in total

1.  Factors of suicide ideation and their relation to clinical and other indicators in older adults.

Authors:  Tracy K Witte; Thomas E Joiner; Gregory K Brown; Aaron T Beck; Anthony Beckman; Paul Duberstein; Yeates Conwell
Journal:  J Affect Disord       Date:  2006-06-05       Impact factor: 4.839

2.  Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age.

Authors:  Katalin Szanto; Benoit H Mulsant; Patricia R Houck; Mary Amanda Dew; Alexandre Dombrovski; Bruce G Pollock; Charles F Reynolds
Journal:  J Affect Disord       Date:  2006-08-24       Impact factor: 4.839

3.  Regional brain metabolic correlates of self-reported depression severity contrasted with clinician ratings.

Authors:  Matthew S Milak; John Keilp; Ramin V Parsey; Maria A Oquendo; Kevin M Malone; J John Mann
Journal:  J Affect Disord       Date:  2010-04-09       Impact factor: 4.839

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Symptom components of standard depression scales and past suicidal behavior.

Authors:  Michael F Grunebaum; John Keilp; Shuhua Li; Steven P Ellis; Ainsley K Burke; Maria A Oquendo; J John Mann
Journal:  J Affect Disord       Date:  2005-07       Impact factor: 4.839

6.  Neuroanatomic correlates of psychopathologic components of major depressive disorder.

Authors:  Matthew S Milak; Ramin V Parsey; John Keilp; Maria A Oquendo; Kevin M Malone; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2005-04

7.  Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.

Authors:  George I Papakostas; Timothy Petersen; Katherine G Sklarsky; Andrew A Nierenberg; Jonathan E Alpert; Maurizio Fava
Journal:  Psychiatry Res       Date:  2006-12-08       Impact factor: 3.222

8.  Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran.

Authors:  Philippe Courtet
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

9.  Course of suicide ideation and predictors of change in depressed older adults.

Authors:  Kelly C Cukrowicz; Paul R Duberstein; Steven D Vannoy; Thomas R Lynch; Douglas R McQuoid; David C Steffens
Journal:  J Affect Disord       Date:  2008-07-09       Impact factor: 4.839

10.  Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.

Authors:  Martin M Katz; Janet L Tekell; Charles L Bowden; Steve Brannan; John P Houston; Nancy Berman; Alan Frazer
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

View more
  19 in total

1.  Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.

Authors:  Michael F Grunebaum; Hanga C Galfalvy; Tse-Hwei Choo; John G Keilp; Vivek K Moitra; Michelle S Parris; Julia E Marver; Ainsley K Burke; Matthew S Milak; M Elizabeth Sublette; Maria A Oquendo; J John Mann
Journal:  Am J Psychiatry       Date:  2017-12-05       Impact factor: 18.112

2.  Depression symptoms and stressful life events among college students in Puerto Rico.

Authors:  Mae Lynn Reyes-Rodríguez; Carmen L Rivera-Medina; Luis Cámara-Fuentes; Alba Suárez-Torres; Guillermo Bernal
Journal:  J Affect Disord       Date:  2012-08-29       Impact factor: 4.839

3.  Depression-related emotional problems mediate the relation between hopelessness and suicidal ideation severity.

Authors:  Roberto López; Lia Follet; Annamarie B Defayette; Emma D Whitmyre; Jennifer Wolff; Anthony Spirito; Christianne Esposito-Smythers
Journal:  J Clin Psychol       Date:  2021-08-10

4.  Internalized Homophobia and Suicide Ideation Among Sexual Minority Adults: The Serial Mediation of Core Self-Evaluations and Depression.

Authors:  Megan Munn; Drexler James
Journal:  Arch Sex Behav       Date:  2022-08-31

5.  The Interactive Effect of Major Depression and Nonsuicidal Self-Injury on Current Suicide Risk and Lifetime Suicide Attempts.

Authors:  Anne C Knorr; Matthew T Tull; Michael D Anestis; Katherine L Dixon-Gordon; Mary F Bennett; Kim L Gratz
Journal:  Arch Suicide Res       Date:  2016-03-08

6.  SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.

Authors:  Michael F Grunebaum; John G Keilp; Steven P Ellis; Katherin Sudol; Neal Bauer; Ainsley K Burke; Maria A Oquendo; J John Mann
Journal:  J Clin Psychiatry       Date:  2013-09       Impact factor: 4.384

7.  Future disposition and suicidal ideation: mediation by depressive symptom clusters.

Authors:  Elizabeth D Ballard; Amee B Patel; Martha Ward; Dorian A Lamis
Journal:  J Affect Disord       Date:  2014-08-27       Impact factor: 4.839

8.  Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups.

Authors:  Shreya Doshi; John G Keilp; Barbara Strobino; Martin McElhiney; Judith Rabkin; Brian A Fallon
Journal:  Psychosomatics       Date:  2018-03-01       Impact factor: 2.386

9.  Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial.

Authors:  Michelle S Parris; Julia E Marver; Sadia R Chaudhury; Steven P Ellis; Allison V Metts; John G Keilp; Ainsley K Burke; Maria A Oquendo; Joseph J Mann; Michael F Grunebaum
Journal:  Int Clin Psychopharmacol       Date:  2018-09       Impact factor: 1.659

10.  Ketamine vs midazolam: Mood improvement reduces suicidal ideation in depression.

Authors:  Annabella Hochschild; John G Keilp; Sean P Madden; Ainsley K Burke; J John Mann; Michael F Grunebaum
Journal:  J Affect Disord       Date:  2021-12-22       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.